Haemonetics Corporation (N:HAE)

Business Focus: Medical Equipment, Supplies & Distribution

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for HAE within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 27th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 19/20 May 18/20 Simon, Christopher Direct Ownership Non-qualified Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 49,105  
May 19/20 May 18/20 Simon, Christopher Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 14,510  
May 19/20 May 18/20 Goldstein Dan Direct Ownership Non-qualified Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 1,841  
May 19/20 May 18/20 Goldstein Dan Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 544  
May 19/20 May 18/20 Goldstein Dan Direct Ownership Common Stock S - Open market or private sale -101 $101.72
May 19/20 May 18/20 Llorens Josep Direct Ownership Non-qualified Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 5,728  
May 19/20 May 18/20 Llorens Josep Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,692  
May 19/20 May 18/20 Lingamneni Anila Direct Ownership Non-qualified Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 4,092  
May 19/20 May 18/20 Lingamneni Anila Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,209  
May 19/20 May 18/20 Scanlan Jacqueline Direct Ownership Non-qualified Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 5,319  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for HAE within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 27th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 19/20 May 18/20 Simon, Christopher Direct Ownership Non-qualified Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 49,105  
May 19/20 May 18/20 Simon, Christopher Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 14,510  
May 19/20 May 15/20 Simon, Christopher Direct Ownership Common Stock S - Open market or private sale -1,008 $100.44
May 19/20 May 18/20 Goldstein Dan Direct Ownership Non-qualified Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 1,841  
May 19/20 May 18/20 Goldstein Dan Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 544  
May 19/20 May 18/20 Goldstein Dan Direct Ownership Common Stock S - Open market or private sale -101 $101.72
May 19/20 May 15/20 Goldstein Dan Direct Ownership Common Stock S - Open market or private sale -42 $100.44
May 19/20 May 18/20 Llorens Josep Direct Ownership Non-qualified Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 5,728  
May 19/20 May 18/20 Llorens Josep Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,692  
May 19/20 May 15/20 Llorens Josep Direct Ownership Common Stock S - Open market or private sale -107 $100.44
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $HAE

  • No tweets found

Competitors

Competitors with Recent Insider Filings
DexCom (OQ:DXCM)
Alpha Pro Tech, (A:APT)
Tandem Diabetes Care (OQ:TNDM)